VIKING GLOBAL INVESTORS LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,366,385 (Position Closed) |
Filing |
| 2022-06-10 4:15 pm Purchase |
2022-05-31 | 13G | Celldex Therapeutics, Inc. CLDX |
VIKING GLOBAL INVESTORS LP | 2,366,385 5.100% |
2,366,385 (New Position) |
Filing |